We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-3.74%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$229B
AUM Growth
-$7.39B
Cap. Flow
+$1.73B
Cap. Flow %
0.76%
Top 10 Hldgs %
35.02%
Holding
11,057
New
1,520
Increased
3,775
Reduced
4,205
Closed
1,444

Sector Composition

Rank Sector Weight
1 Technology 2.23%
2 Consumer Discretionary 2.03%
3 Financials 1.67%
4 Communication Services 1.15%
5 Healthcare 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYMC icon
8926
PUT
Hycroft Mining Holding Corp
HYMC
$2.47B
$39K ﹤0.01%
6,500
-12,360
-66% -$110K
ORGNW
8927
DELISTED
Origin Materials Inc Warrants
ORGNW
$39K ﹤0.01%
37,340
-2,882
-7% -$3.43K
QCLS
8928
Q/C Technologies Inc
QCLS
$22.9M
$39K ﹤0.01%
5
+1
+25% +$11K
CBAY
8929
DELISTED
Cymabay Therapeutics
CBAY
$39K ﹤0.01%
11,253
-999
-8% -$3.59K
BBIG
8930
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$39K ﹤0.01%
2,069
-9,100
-81% -$181K
APTX
8931
DELISTED
Aptinyx Inc. Common Stock
APTX
$39K ﹤0.01%
105,771
+72,006
+213% +$36.1K
FCRD
8932
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$39K ﹤0.01%
+13,651
New +$44.9K
JCICW
8933
DELISTED
Jack Creek Investment Corp. Warrants
JCICW
$39K ﹤0.01%
150,037
CLVS
8934
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
$39K ﹤0.01%
32,800
-258,600
-89% -$403K
LASE icon
8935
Laser Photonics
LASE
$57.2M
$38K ﹤0.01%
+14,651
New +$37.8K
LCTX icon
8936
Lineage Cell Therapeutics
LCTX
$278M
$38K ﹤0.01%
34,022
-24,955
-42% -$36.6K
PHUN icon
8937
Phunware
PHUN
$43.6M
$38K ﹤0.01%
644
-2,735
-81% -$196K
PRENW
8938
Prenetics Global Ltd Warrant
PRENW
$161K
$38K ﹤0.01%
84,404
-801
-0.9% -$254
SACH
8939
Sachem Capital Corp
SACH
$39.8M
$38K ﹤0.01%
11,344
-22,888
-67% -$102K
XBIT icon
8940
XBiotech
XBIT
$69.2M
$38K ﹤0.01%
+10,439
New +$49.1K
EXN
8941
DELISTED
Excellon Resources Inc.
EXN
$38K ﹤0.01%
+113,210
New +$44.7K
CTXR icon
8942
Citius Pharmaceuticals
CTXR
$18.7M
$37K ﹤0.01%
+1,225
New +$33.7K
EVLVW
8943
DELISTED
Evolv Technologies Warrant
EVLVW
$37K ﹤0.01%
77,800
-275
-0.4% -$146
FOXO
8944
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$37K ﹤0.01%
+144
New +$245K
GROW icon
8945
US Global Investors
GROW
$38.5M
$37K ﹤0.01%
12,755
-8,934
-41% -$34.7K
ONCO icon
8946
Onconetix
ONCO
$3.29M
0
LENZ
8947
LENZ Therapeutics
LENZ
$168M
$37K ﹤0.01%
+1,649
New +$39.3K
GATO
8948
DELISTED
Gatos Silver, Inc.
GATO
$37K ﹤0.01%
14,123
-15,255
-52% -$47.7K
BGXX
8949
CALL
DELISTED
Bright Green Corporation Common Stock
BGXX
$37K ﹤0.01%
+34,000
New +$52.6K
NRDY.WS
8950
DELISTED
Nerdy Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
NRDY.WS
$37K ﹤0.01%
91,614
+100
+0.1% +$40

Similar funds

Jane Street's Q3 2022 Portfolio in Review

As of Q3 2022, Jane Street held 11,057 positions worth $229B, down 3.1% from $236B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Jane Street's Q3 2022 filing shows 1,520 new, 3,775 increased, 4,205 reduced and 1,444 closed positions. Its largest new stake was iShares Gold Trust: 8,373,079 shares worth $264M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $1.05B.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jane Street's largest Q3 2022 buy was iShares Gold Trust: 8,373,079 shares worth $264M.
  • Jane Street added most to Invesco QQQ Trust in Q3 2022, an estimated $1.36B increase.
  • Jane Street's biggest Q3 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.05B.
  • Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2022, selling an estimated $187M.
  • Jane Street's ten largest holdings make up 35% of its $229B portfolio in Q3 2022.
  • Jane Street opened 1,520 new positions and closed 1,444 in Q3 2022.
  • Jane Street's portfolio value fell 3.1% quarter-over-quarter to $229B.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.